Altogether, the modification of the expression of specific genes encoding for proteins involved in the HSPB8-mediated PQC response here reported, may provide muscle specific biomarkers which could allow to follow the progression of disease in SBMA mice and patients during the validation of therapeutic trials. This evidence concerns the gene HSPB8 and Kennedy disease.